SAT-287 Metabolic comorbidities are risk factors for adverse liver-related events in individuals with HIV-HBV on tenofovir-based antiretroviral therapy
0Citations signalées
0Institutions associées
0Pays d’affiliation
Résumé indisponible dans les métadonnées reçues.
Sujets associés
Liver Disease Diagnosis and TreatmentHIV-related health complications and treatmentsHepatitis C virus research